FDA 510(k) · Masimo

K213676: Masimo Rad-G with Temperature (Masimo Corporation)

Masimo Corporation received FDA 510(k) K213676 for Masimo Rad-G with Temperature, with a decision date of Apr 16, 2023 (substantially equivalent).

Prescription or OTC: Unknown (no FDA document we parsed states it).

FDA record for K213676

FDA facts

Official fields for K213676
FDA numberK213676
Pathway510(k)
ApplicantMasimo Corporation
Device nameMasimo Rad-G with Temperature
Product codeDQA: Oximeter
Regulation (21 CFR)870.2700
Device classClass 2
Date receivedNov 22, 2021
Decision dateApr 16, 2023
DecisionSubstantially Equivalent (SESE)
510(k) typeTraditional

Source: openFDA device 510(k) data, data through Oct 26, 2026.

Indications for use parsed from FDA documents

We could not extract the indications for this record because FDA's summary PDF was not available at the usual address. Check the FDA record for its summary or statement.

Predicates parsed from FDA documents

No predicate numbers were parsed for this record. The FDA summary, if available, names the predicate.

ChatPPG interpretation

A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.

Product code DQA is "Oximeter", class 2, 21 CFR 870.2700.

Our labels for filtering: claim SpO2 / pulse oximetry, sensor Finger PPG. These are heuristics, not FDA fields.